This Pipeline LP Pays You Just To Hold It

Daniel Cross - INO.com Contributor - Equities


There's nothing like an investment that pays off even if there's no capital appreciation. That's the appeal of renting out your home instead of selling it – you get income along with and investment. The way markets are behaving right now with the Fed rate hike delayed once again, most likely until 2016, and uncertainty driving investor decisions, picking a stock that can pay out in more than one way is a huge benefit.

Limited partnership entities differ from traditional corporations in the sense that they are obligated to pass on a lion's share of the profits to shareholders. That gives them an edge when it comes to dividend yields and makes them defensive even if they're not necessarily in a defensive sector of the economy.

The oil and gas pipeline industry might not seem like a defensive environment given what's happened with commodities and energy prices, but this sub-sector operates a little differently. Pipelines are more on the midstream segment of energy operations giving them a more stable business with steady growth prospects regardless of energy prices. Continue reading "This Pipeline LP Pays You Just To Hold It"

How To Invest Alongside "Shark Tanks" Kevin O'Leary

Matt Thalman - INO.com Contributor - ETFs


Up until just a few years ago the name Kevin O'Leary didn't mean much to most investors. But, with O'Leary starring on the hit TV show "Shark Tank", now most investors, as well as the general public at least, recognize the name. Furthermore, if you often watch Shark Tank you likely have a good idea of how "Mr. Wonderful", O'Leary's nickname on Shark Tank, likes to invest.

Mr. O'Leary often asks for a royalty deal, a few dollars every time an item is sold when giving entrepreneurs money. While some of the other investors on the show often criticize O'Leary for building in the royalty deal, claiming he is taking advantage of people, the idea behind the royalty is so that O'Leary can get his initial investment back in a reasonable amount of time. Furthermore, it acts as a safety net for O'Leary if the company he invests in is a massive winner at first but, doesn’t have the longevity to grow and become a long-term successful organization.

While the sarcastic nickname O'Leary has received on the show may not make him the best partner for an entrepreneur, it shows that he not only is a wise investor but someone that limits their risk as much as possible. For some investors, this sounds like the kind of guy they would love to be able to invest with. I mean honestly, who hasn’t watched Shark Tank and thought to themselves how cool it would be if they could partner with one of the investors on the show?

Well, you know can! Continue reading "How To Invest Alongside "Shark Tanks" Kevin O'Leary"

A New Immunotherapy ETF Has Launched

Noah Kiedrowski - INO.com Contributor - Biotech


Update

I previously wrote an article laying the groundwork for an exciting immunotherapy ETF launching in the second half of 2015, “A Niche ETF In The Potentially Promising Future Of Immunotherapy Is On The Horizon.” Loncar Investments has teamed up with an ETF firm and finally launched its immunotherapy ETF, Loncar Cancer Immunotherapy ETF (ticker symbol: CNRC). I wanted to update readers on the latest information and launch of the ETF as many readers requested.

Introduction

Immunotherapy has emerged as an exciting therapeutic area that has experienced massive growth over the past few years in terms of research and development expenditures and a sheer number of clinical trials throughout the biotechnology sector. Immunotherapy ushers in a new class of potentially promising therapies by leveraging the immune system to recognize and eradicate debilitating diseases, specifically cancer and chronic viral infections. This immunotherapy approach may inevitably result in a paradigm shift from traditional medical intervention. Immunotherapy possesses holistic attributes by harnessing the body’s immune system to contend with the disease. Continue reading "A New Immunotherapy ETF Has Launched"

6 Ways To Play The Biotech Industry Moving Forward

Matt Thalman - INO.com Contributor - ETFs


In September Biotech stocks got hammered. Most market participants blamed the massive decline on Democratic Presidential candidate Hillary Clinton. On September 21, Clinton tweeted "Price gouging like this in the specialty drug market is outrageous. Tomorrow I'll lay out a plan to take it on." Clinton was referring to a drug called Daraprim, a 65-year-old drug, which recently saw its price increase from $13.50 per pill to $750.

While there are arguments for and against why Daraprim and other drugs increase in price, an industry-wide reform on how prices are set would likely hurt nearly every company in the biotech space. And that was what Clinton essentially proposed last month. With uncertainty surrounding the industry, the NASDAQ Biotechnology Index (NBI) fell by more than 15% just in September compared to a decline of just 4.4% for the S&P 500 during the month. Continue reading "6 Ways To Play The Biotech Industry Moving Forward"

This Forgotten Stock Could Be About To Break Out

Daniel Cross - INO.com Contributor - Equities


Wall Street is a fickle environment that often focuses on hot new growth plays prioritizing chasing the next big thing to replace already established names like Apple or Google. "Sexy" investments like technology companies and niche industries may capture the headlines, but experienced investors know that consistency is the key to long-term success in the stock market.

Businesses don't need to be involved in the latest trends or the hottest new emerging market in order to make outstanding profits. There are plenty of industries with stable growth prospects that are engaged in mundane services and easily overlooked.

The waste and recycling management industry fits the definition of an "unsexy" investment perfectly. It's not a glamorous business on the surface, but looks can be deceiving. Thanks to a heavy push for green initiatives, this industry has been reinventing itself over the past decade and could offer investors an opportunity for higher gains. Continue reading "This Forgotten Stock Could Be About To Break Out"